Industry News-Keysee Medtech

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel a Structured Market Rally; AI in Healthcare Opens Up New Growth Opportunities

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel a Structured Market Rally; AI in Healthcare Opens Up New Growth Opportunities

During the third week of February 2025, the pharmaceutical and biotechnology sector continued to exhibit structural divergence. Over the week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming both the CSI 300 Index and the Shanghai Composite Index, ranking ninth in terms of sector performance.

01

2025

/

03

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Recently, the pharmaceutical and biotechnology sector has exhibited a pronounced structural market trend, driven by the deep integration of AI technologies with healthcare applications, which is spurring industry-wide upgrades. At the same time, policy support for innovative drugs continues to strengthen, creating multiple favorable factors for the sector.

01

2025

/

03

With the concerted support of 17 government departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

With the concerted support of 17 government departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

Recently, the “Policy Measures for Coordinated Support from Relevant Provincial Departments for the Open and Innovative Development of the Biopharmaceutical Industry in the China (Jiangsu) Pilot Free Trade Zone” (hereinafter referred to as the “Policy Measures”) were officially released!

01

2025

/

03

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

Regenerative medicine technologies, exemplified by stem cell technology, represent the “third medical revolution” following pharmacological and surgical therapies. Stem cells possess the remarkable ability to differentiate into and form any type of tissue in vivo, as well as to self-renew and generate additional stem cells, making them a key frontier area of international medical research in recent years.

01

2025

/

03

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

In recent years, Chinese enterprises have actively invested in research on the application of AI-powered medical imaging software in the field of cardiovascular diseases, resulting in the approval and launch of several products, primarily focused on niche areas such as coronary CT angiography and auxiliary analysis of electrocardiograms.

01

2025

/

03

< 1 2 >

Keysee

Polymer tubing

Intervention in consumables OEM

Company Profile
Culture

Neuro Intervention

Peripheral Intervention

Cardiovascular Intervention

Contact Information

IMFORMATION

Contact: Manager Zhang

Tel: +86 15026990525
Email: mkt001@keyseemed.com
Address: No. Y6, Lane 18, Weihang Road, Baoshan District, Shanghai

Contact: Manager Xu
Tel: +86 18994298366
Email: mkt004@keyseemed.com
Address: Building 1, No. 300, Baichuan Road, Haian High-tech Zone

Business license

Jiangsu Keysee Medical Technology Co., Ltd. 丨SEO

Power By 300.cn